MedTrace Logo

Music Therapy Protocol to Support Bulbar and Respiratory Functions in ALS

NCT03604822 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2018-07-30

No results posted yet for this study

Summary

This study evaluates potential of music therapy treatment to support breathing, speech, swallow and cough of persons with amyotrophic lateral sclerosis (ALS). Music therapy is the clinical use of music and its elements to enhance human health and wellbeing. Application of music therapy principles in neurorehabilitation allow to treat cognitive, sensory, and motor dysfunctions.

Conditions

  • Motor Neuron Disease, Amyotrophic Lateral Sclerosis
  • ALS (Amyotrophic Lateral Sclerosis)
  • Dysarthria, Flaccid
  • Dysarthria, Spastic
  • Dysarthria, Mixed
  • Dysphagia
  • Dyspnea
  • Aspiration Pneumonia
  • Hypernasality
  • Breathlessness

Interventions

PROCEDURE

Music therapy

ALS-specific, individualized MT protocol was delivered to study participants in their homes twice weekly for the duration of six weeks by the researcher. Facilitating music structures were composed by the researcher to support cueing, timing and intensity of breathing and vocalization exercises. These structures were regularly modified to suit the unique capabilities, current individual demands and progress of each participant. One familiar song, selected by the participant, was used for each participant in therapeutic singing exercise closing each session. Individualized exercises sets for independent practice were provided at session 3 to each participants. ALS-specific voice health guidelines were provided for participants prior to start of the treatment.

Sponsors & Collaborators

  • ALS Centre Moscow

    collaborator UNKNOWN

  • Alisa Apreleva

    lead OTHER

Principal Investigators

  • Alisa Apreleva, MA · Anglia Ruskin University

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-27
Primary Completion
2018-07-31
Completion
2020-01-01

Countries

  • Russia
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03604822 on ClinicalTrials.gov